MedPath

A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia.

Phase 1
Conditions
Obstructed defeacation
Registration Number
EUCTR2005-001378-29-GB
Lead Sponsor
Bradford Teaching Hospitals NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Presence of obstructed defeacation according to the Rome II criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Unfit for general anaesthesia, hypersensitivity to Botox, Myaesthenia gravis, Eaton Lamberrt Syndrome

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Relieve paradoxical puborectalis contraction in obstructed defeacation;Secondary Objective: Improve quality of life and constipation scores;Primary end point(s): Improved defeacation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath